| Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized … S Rögnvaldsson, TJ Love, S Thorsteinsdottir, ER Reed, JÞ Óskarsson, ... Blood Cancer Journal 11 (5), 94, 2021 | 125 | 2021 |
| Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study TE Long, OS Indridason, R Palsson, S Rognvaldsson, TJ Love, ... Blood cancer journal 12 (9), 133, 2022 | 122 | 2022 |
| Prevalence of smoldering multiple myeloma based on nationwide screening S Thorsteinsdóttir, GK Gíslason, T Aspelund, S Rögnvaldsson, ... Nature medicine 29 (2), 467-472, 2023 | 80 | 2023 |
| Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study AÝ Sigurbergsdóttir, S Rögnvaldsson, S Thorsteinsdóttir, I Sverrisdóttir, ... Haematologica 108 (12), 3392, 2023 | 32 | 2023 |
| Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls S Rögnvaldsson, V Steingrímsson, I Turesson, M Björkholm, O Landgren, ... Haematologica 105 (11), 2679, 2020 | 31 | 2020 |
| Deciphering the genetics and mechanisms of predisposition to multiple myeloma M Went, L Duran-Lozano, GH Halldorsson, A Gunnell, ... Nature Communications 15 (1), 6644, 2024 | 27 | 2024 |
| Screening for monoclonal gammopathy of undetermined significance: a population-based randomized clinical trial. First results from the Iceland Screens, Treats, or Prevents … SY Kristinsson, S Rögnvaldsson, S Thorsteinsdottir, ER Reed, ... Blood 138, 156, 2021 | 23 | 2021 |
| Revised definition of free light chains in serum and light chain monoclonal gammopathy of undetermined significance: results of the istopmm study TE Long, S Rögnvaldsson, S Thorsteinsdottir, I Sverrisdottir, E Eythorsson, ... Blood 142, 535, 2023 | 21 | 2023 |
| Development of a multivariable model to predict the need for bone marrow sampling in persons with monoclonal gammopathy of undetermined significance: a cohort study nested in a … E Eythorsson, S Rognvaldsson, S Thorsteinsdottir, T Einarsson Long, ... Annals of internal medicine 177 (4), 449-457, 2024 | 19 | 2024 |
| Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study S Snorradottir, A Asgeirsdottir, S Rögnvaldsson, JG Jonasson, ... Cancer Epidemiology 79, 102197, 2022 | 17 | 2022 |
| Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and … S Rögnvaldsson, TJ Love, S Thorsteinsdottir, ER Reed, JÞ Óskarsson, ... Blood Cancer Journal 13 (1), 39, 2023 | 14 | 2023 |
| Prevalence of MGUS is high in the Istopmm study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do TJ Love, S Rögnvaldsson, S Thorsteinsdottir, T Aspelund, ER Reed, ... Blood, The Journal of the American Society of Hematology 140 (Supplement 1 …, 2022 | 14 | 2022 |
| Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls UA Shah, S Rögnvaldsson, A Derkach, M Björkholm, I Turesson, Y David, ... haematologica 107 (1), 284, 2021 | 14 | 2021 |
| Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index JÞ Óskarsson, S Rögnvaldsson, S Thorsteinsdottir, T Aspelund, ... Blood cancer journal 13 (1), 177, 2023 | 13 | 2023 |
| Validity of chronic disease diagnoses in Icelandic healthcare registries S Rögnvaldsson, TE Long, S Thorsteinsdottir, TJ Love, SY Kristinsson Scandinavian journal of public health 51 (2), 173-178, 2023 | 13 | 2023 |
| Prevalence of smoldering multiple myeloma: results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study S Thorsteinsdottir, GK Gislason, T Aspelund, S Rögnvaldsson, ... Blood, The Journal of the American Society of Hematology 138 (Supplement 1 …, 2021 | 13 | 2021 |
| Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study O Pérez-Escurza, J Flores-Montero, JÞ Óskarsson, L Sanoja-Flores, ... Blood Cancer Journal 13 (1), 182, 2023 | 11 | 2023 |
| Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study S Rognvaldsson, E Eythorsson, S Thorsteinsdottir, B Vidarsson, ... Blood cancer journal 11 (12), 191, 2021 | 11 | 2021 |
| Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population‐based cohort study S Rögnvaldsson, T Aspelund, S Thorsteinsdóttir, I Turesson, M Björkholm, ... European journal of haematology 107 (1), 137-144, 2021 | 10 | 2021 |
| Association between autoimmune diseases and monoclonal gammopathy of undetermined significance: an analysis from a population-based screening study I Sverrisdottir, S Thorsteinsdottir, S Rognvaldsson, T Aspelund, ... Annals of Internal Medicine 177 (6), 711-718, 2024 | 9 | 2024 |
Sigurður Yngvi KristinssonFaculty of Medicine, University of Iceland and Department of Hematology, Landspitali NationalVerified email at hi.is
